New York State Common Retirement Fund’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$117K	Hold	12,543	–	–	﹤0.01%	2455
2025 Q4	$94.1K	Hold	12,543	–	–	﹤0.01%	2628
2025 Q3	$109K	Hold	12,543	–	–	﹤0.01%	2577
2025 Q2	$46.5K	Hold	12,543	–	–	﹤0.01%	2959
2025 Q1	$40.5K	Hold	12,543	–	–	﹤0.01%	2842
2024 Q4	$69.9K	Sell	12,543 -3,100	-20%	-$24.3K	﹤0.01%	2741
2024 Q3	$169K	Sell	15,643 -5,400	-26%	-$89.6K	﹤0.01%	2379
2024 Q2	$442K	Buy	21,043 +3,868	+23%	+$97K	﹤0.01%	2091
2024 Q1	$547K	Sell	17,175 -2,247	-12%	-$57.3K	﹤0.01%	2040
2023 Q4	$393K	Buy	19,422 +5,609	+41%	+$73.8K	﹤0.01%	2189
2023 Q3	$176K	Buy	13,813 +197	+1%	+$3.29K	﹤0.01%	2482
2023 Q2	$246K	Sell	13,616 -2,545	-16%	-$46.9K	﹤0.01%	2402
2023 Q1	$278K	Sell	16,161 -3,473	-18%	-$67.5K	﹤0.01%	2455
2022 Q4	$436K	Sell	19,634 -27	-0.1%	-$417	﹤0.01%	2379
2022 Q3	$158K	Buy	19,661 +9,956	+103%	+$90.2K	﹤0.01%	2853
2022 Q2	$68K	Sell	9,705 -13,239	-58%	-$129K	﹤0.01%	3188
2022 Q1	$347K	Buy	22,944 +8,570	+60%	+$135K	﹤0.01%	2570
2021 Q4	$315K	Buy	14,374 +4,879	+51%	+$120K	﹤0.01%	2684
2021 Q3	$256K	Buy	9,495 +1,734	+22%	+$49.4K	﹤0.01%	2811
2021 Q2	$187K	Buy	7,761 +4,261	+122%	+$130K	﹤0.01%	3066
2021 Q1	$152K	Buy	+3,500	New	+$155K	﹤0.01%	2932